Skip to main content
PLOS One logoLink to PLOS One
. 2026 May 14;21(5):e0348971. doi: 10.1371/journal.pone.0348971

Out-of-pocket payments and associated factors among hypertensive patients insured under the National Health Insurance Scheme in a referral hospital, Ghana

Angela Nana Esi Ackon 1,*, Hubert Amu 2, Martin Amogre Ayanore 1
Editor: Charles C Ezenduka3
PMCID: PMC13175461  PMID: 42133739

Abstract

Introduction

Out-of-pocket (OOP) payments are a common component of healthcare financing in many low-and middle-income countries including Ghana. Despite implementation of the National Health Insurance Scheme in Ghana which is expected to protect against catastrophic OOP payments, patients still make some form of payments with its attendant negative implications for improved health status. We examined the prevalence and self-reported effects of OOP payments among hypertensive patients insured under the National Health Insurance Scheme attending a referral hospital in Hohoe, Ghana.

Methods

This was a cross-sectional study conducted among 389 hypertensive patients between February and May 2022 using a structured questionnaire. Data collected were analysed using Stata software version 15. We employed descriptive statistics and logistic regression in analysing the data. Statistical significance was considered at p < 0.05.

Results

A total of 97.2% respondents made OOP payments in receiving healthcare with 97.1% of those who made such payments having made them at the point of receiving drugs. Difficulty in making OOP payments was reported by 29.1% of the respondents and this was associated with ever borrowing money to cover health expense (aOR=2.52; 95% CI: 1.31–4.88; p = 0.006), OOP payments affecting hospital attendance (aOR=5.52; 95% CI: 2.74–11.11; p < 0.001) and having an alternative form of treating hypertension (aOR=2.93; 95% CI: 1.60–5.38; p = 0.001).

Conclusion

OOP payments are widespread in the utilisation of healthcare for hypertensive patients. This raises concerns about progress towards the attainment of Sustainable Development Goals (SDGs) 3.4 which seeks to control non-communicable diseases and SDG 3.8 which seeks to ensure universal health coverage. Medications or drugs are the major healthcare services for which individual hypertensive patients made OOP payments thus highlighting the need ensure availability and accessibility of drugs to meet the global targets of SDG 3 and due to the long-term treatment requirements of hypertension.

Introduction

Out-of-pocket (OOP) payments lead to financial and non-financial barriers in healthcare access [1] and such payments are a common component of healthcare financing in low- and middle-income countries (LMICs). OOP expenditure by households is reported as a regressive pathway to financing healthcare since it leads to the risk of catastrophic payments by households who do not have adequate financial protection [2]. OOP payments refer to payments, both formal and informal, that are made while accessing healthcare and these include payment for medical supplies, consultation fees and payment for laboratory tests [1]. It also includes any direct remittance by households to healthcare providers which is primarily intended to restore or enhance health of an individual or group [3].

The establishment of the National Health Insurance Scheme (NHIS), a public health financing scheme which delivers accessible, affordable, and good quality health care to all Ghanaians especially the poor and most vulnerable in society [4], is an important pathway towards Ghana’s ambition to achieve Universal Health Coverage (UHC) [5,6].

Nevertheless, patients seeking health services are confronted with payments such as user fees, payment for medicines, consultation fees, and informal fees, which create a huge gap in achieving UHC in Ghana and other LMICs [7]. OOP payments are common at all levels of health facilities in the country with about 40–53% of patients making payments and approximately 47% of Ghana’s NHIS clients with valid cards reportedly making OOP payments for out-patient-department (OPD) services [8]. Although subscription to the NHIS has reduced household OOP payments by 86%, some insured households still make OOP payments [2,7].

People with chronic conditions need follow-up visits and long-term use of medications making them more prone to OOP payments and invariably catastrophic health expenditure [9] with chronic non-communicable diseases (CNCDs) becoming increasingly burdensome to health care systems worldwide and about 71% of all global deaths attributable to CNCDs [10]. Hypertension remains one of the major CNCDs which also serves as a risk factor for the development of cardiovascular disease (CVD) [11].

The burden of hypertension among Ghanaians is high, with one out of every four persons having the condition [12]. Among older adults, as many as 53.7% were hypertensive [13].

CNCDs including hypertension require considerable financial resources to manage. The costs involved include medications and transportation costs for hospital reviews [14]. Ghana’s NHIS is expected to cover over 95% of disease conditions that afflict Ghanaians as stated in the policy framework that established the scheme [15] and this includes the management of hypertension. The categories of medications for treatment of hypertension are quite common for persons with the condition in Ghana.

A challenge, however, is the unavailability of these essential drugs at lower-level service delivery points [16]. Also, not all the drugs are listed on the NHIS medicines list and the ones listed for hypertension are usually not accessible to patients due to frequent drug shortages in many medical stores in the country [17]. This will invariably compel the hypertensive patient to make OOP payments at the point of healthcare utilisation. OOP payments have brought poverty and financial disaster upon many individuals and households in many countries with about 100 million persons being pushed below the poverty line globally due to healthcare utilisation and its associated OOP payments which leads to persons not seeking required health services due to financial circumstances and this has a ripple effect where they suffer due to ill health, lose their jobs and sink further into poverty [18,19].

The Sustainable Development Goals (SDGs) represent a clarion call for every member of the United Nations to commit to peace and prosperity of all their citizens [20]. The third goal of the SDGs primarily seeks to ensure and promote health and wellbeing for everyone irrespective of age with achieving UHC and the control of non-communicable diseases (NCDs) as some of the key targets under SDG 3 [21]. OOP payments however threaten the attainment of UHC under SDG 3.8 and OOP payments particularly among hypertensive patients subscribed to health insurance dim the prospects of attaining SDG 3.4.

Earlier studies on OOP payments in Ghana have mainly sought to examine the impact of the NHIS on OOP payments and catastrophic health expenditure [2,7,8,22,23]. However, it is also imperative to determine the difficulties that insured individuals undergo when they are faced with OOP payments. Given the increasing reports of OOP payments at various health facilities in Ghana [2,8,24] and considering the long-term healthcare requirement of hypertension, a study on OOP payments among hypertensive patients who are subscribed to the NHIS was needed. In this paper, our contribution to the literature on OOP payments determines the prevalence and self-reported effects of making OOP payments by hypertensive patients who are subscribed to the NHIS.

Methods

Our study followed the ‘Strengthening the Reporting of Observational studies in Epidemiology’ (STROBE) directive guidelines for observational studies [25].

Study design

This is a health facility-based cross-sectional study. This study design was employed due to its ability to examine multiple exposure variables of an outcome among a study population [26].

Study settings

The study was conducted between February 2022 and May 2022 at the Volta Regional Hospital, located in the Hohoe Municipality of the Volta Region, Ghana. Hohoe is one of the 18 districts/municipalities in the Volta Region and is in the northern part of the region. The municipality shares boundaries on the north with Jasikan District, Biakoye District on the north-west, Kpando Municipality on both west and south-west, Afadjato South District on the south and on the east with the Republic of Togo. The municipality consists of one hundred and two communities with an estimated 2021 population of 216,038 based on the 2010 national population census at an annual growth rate of 2.5%. Major economic activities include farming (about 55%), trading (about 25%), livestock rearing (about 15%) and others (about 5%). The municipality has been divided into 7 sub-municipalities namely Akpafu/Santrokofi, Alavanyo, Agumatsa, Lolobi Gbi-South, Hohoe-Sub and Likpe. It has a total of twenty-six (26) health institutions including the Volta regional hospital, a polyclinic, a research centre, 19 health centres, a private hospital and 33 CHPS zones. There is also a midwifery training school which is a diploma awarding institution in midwifery [27].

The Volta Regional Hospital, Hohoe where the study was conducted, was established in 1940 and has been upgraded to the status of a regional hospital upon the conversion of the former Volta regional hospital, Ho into a teaching hospital [28]. The facility is led by a medical director with support from the various heads of units. Essential units within the hospital include the Obstetrics and Gynaecology unit (O&G), the OPD, the administration, the physiotherapy unit among others. CNCD cases are typically managed at the OPD and the hypertension clinic. The hospital is an NHIS accredited facility and provides general services.

Inclusion and exclusion criteria

All hypertensive patients accessing care at the Volta regional hospital, Hohoe and insured under the NHIS were included in the study. The exclusion of potential respondents in this study was based on all those who met the inclusion criteria but were seriously ill at the time of the data collection, not of sound mind, or did not attend the hospital during the period of data collection. For the purposes of this study, a hypertensive patient is a person aged 18 years and above with either systolic blood pressure >140 mmHg or diastolic blood pressure >90 mmHg or those taking anti-hypertensive treatment regardless of their blood pressure on measurement [12].

Hypertensive patients who subscribed to the NHIS were selected using a systematic random sampling technique. Approximately 80 patients visited the hypertensive clinic at each clinic session at the Volta regional hospital and 60 hypertensive patients were systematically selected each clinic day to participate in the study for a period of two months until the required sample size of hypertensive patients was obtained. A balloting without replacement method was used for randomisation. “Yes” and “No” were written on pieces of paper and then folded. The folded pieces were then placed in a basket and tumbled to ensure a good mix. In the situation where patients visiting the hypertensive clinic were less than 80, all eligible patients present were allowed to participate in the study after consenting voluntarily. To ensure that a respondent did not participate more than once in this study, prospective respondents were asked after data collection had taken place for four weeks if they had met the data collection team. This was because the patients had a usual review schedule of monthly and once every two months. In addition, phone numbers of the respondents were collected and checked for duplicates as a double measure.

Study variables

Outcome variables.

In our study, the primary outcome variable is making OOP payments which indicates the payment of money for accessing healthcare at the hospital. This was determined by posing the question “Were you made to pay for any of the services?” to the respondents with responses as either a “yes” or “no”. The preceding question sought to determine which health services the respondent assessed and followed up with whether payments had been made for any of those payments, providing a detailed breakdown of possible health services that may have resulted in payments. Informal payments and co-payments were included. Our study, however, excluded payments made outside of the health facility since we sought to examine the OOP payments made by NHIS subscribers. It was coded “1” if a respondent reported having been asked to make any payment and “0” if otherwise.

The secondary outcome variable is a binary variable which measures the self-reported difficulty that arises due to having made OOP payments for healthcare utilisation. This was a follow-up question for respondents who made OOP payments. It was determined by the question “Did you have difficulty making these payments?” with responses as either a “yes” or “no”. It was coded “1” if a respondent reported having difficulties in making OOP payments and “0” if otherwise.

Explanatory variables

The explanatory variables fell under two categories: namely socio-demographic variables and the contextual factors of making OOP payments. The socio-demographic variables consisted of age, sex, religion, marital status, educational level, occupation, form of income and level of income earned. On the other hand, service for which OOP payments were made, amount of money paid as OOP payments, source of money used to pay for OOP payments, reasons for making OOP payments, ever borrowing money to attend the hospital, self-reported effects of OOP payments on managing hypertension and alternative means of managing hypertension were considered the contextual variables.

Sampling

Sample size determination.

Using the cross-sectional study formula [29] with an expected OOP payment prevalence of 47% [8] and assuming a z-statistic for a 95% level of confidence and a 5% margin of error, the appropriate minimum sample size was estimated for the study as:

n=Z2(1p)pd2

Where:

n = sample size

Z = Confidence interval of 95% (standard value of 1.96)

P = expected prevalence or proportion; 0.47 [8]

d = precision: 5% margin of error; 0.05

Considering these assumptions, the actual sample size for the study was calculated using the formula: n=(1.922)×0.47×(10.47)0.052

n = 382.77

Adjusting for non-response rate of 10% of 383 = 422

This study however recruited 393 respondents due to practical recruitment constraints

Data collection

We used a structured questionnaire to collect data for this study. The questionnaires were in English but in instances where a respondent did not understand English, it was translated into either Ewe or Twi by a local translator. The administration of each questionnaire took at least 25 minutes.

There were four sections on the questionnaire namely; A, B, C, and D. Sociodemographic information on the respondents was recorded in Section A. Data on the proportion of hypertensive patients subscribed to the NHIS who had made OOP payments was captured in Section B. Section C captured the factors influencing OOP payments and Section D contained questions on the perceived influence of OOP payments on respondents’ accessing healthcare.

Each questionnaire was assigned a unique code before data collection. At the end of the field work, a secure database was created to contain all the information about the study respondents. Pre-testing was carried out in the Ho municipality of the Volta Region to fine-tune the questions. Data were collected using KoBo Toolbox v2022.1.2 software on a face-to-face basis with strict adherence to COVID-19 protocols. The data collection for this study started on the 8th of February 2022 and ended on the 7th of May 2022. All OOP payments and income in the study were collected in GHC, and the results are presented in GHC with the USD equivalent in brackets, using the average exchange rate of May 2022 when data collection ended (USD 1 = GHC 7.13) [30].

Data analysis

Data was exported from Kobo Toolbox into Microsoft Excel 2016 for cleaning and validation to ensure quality before analysis began. Cleaning of the data was done by running frequencies of the variables to check for inconsistencies in data coding. For analysis, the cleaned data were exported to STATA Windows version 15.0. Descriptive statistics were used to describe respondents’ socio-demographic characteristics, the proportion of respondents who made OOP payments, reasons for making OOP payments and the self-reported effects of OOP payments on their health status and demand for healthcare. The results are presented as proportions and means and are displayed in tables, pie chart and graphs. Pearson Chi-square test or Fisher’s exact test (where expected cell count is < 5) was used to determine the association between making OOP payments and socio-demographic variables. Multiple logistic regression was used to determine factors that influenced difficulty in making OOP payments with statistical significance considered based on a p-value of <0.05 at a confidence interval of 95%. The results are presented as odds ratios.

Ethical considerations

This study received ethical approval from the University of Health and Allied Sciences’ (UHAS) Research Ethics Committee (REC); UHAS REC Protocol identification number UHAS-REC A.3 [3] 21–22. Permission and approval were obtained from the medical director of the Volta regional hospital. Consent to participate in the study was also obtained through written informed consent forms from the participants. The consent form contained information on the objectives of the study, risks, benefits and freedom of participation, and confidentiality.

Results

Socio-demographic characteristics of respondents

Table 1 presents socio-demographic characteristics of the respondents. The number of questionnaires administered was 393 but 4 were incomplete and were therefore not included in the analysis. The response rate was thus 99%. Females represented 82.3% of the respondents. The mean age of the respondents was 66 ± 11.87 years. Only 5.9% of the respondents were below 50 years old and the rest were above 50 years. Based on religious affiliation, a greater proportion of the participants (93.3%) were Christians. With respect to marital status, 65.3% of the respondents were not married. In addition, less than half of the respondents (20.6%) had no form of education and the rest had some form of education. With regards to occupation, 26.7% of the respondents were unemployed, 16.4% were retired, 27.8% were into sales and services, 26.0% were into agriculture or manual work and 3.1% were clerical workers. In addition, more than half of the respondents (58.2%) earned less than GH¢500.00 (equivalent of USD70.13) as monthly income and the rest earned GH¢500.00 (USD70.13) and above.

Table 1. Socio-demographic characteristics of respondents.

Variable Frequency (n = 389) Percent (%)
Mean age (SD) 66 (11.87)
Age (in years)
<50 23 5.9
50-59 100 25.7
60-69 109 28.0
70-79 89 22.9
80+ 68 17.5
Sex
Male 69 17.7
Female 320 82.3
Religion
Christianity 363 93.3
Islam 26 6.7
Marital status
Separated/Never married 29 7.5
Married 174 44.7
Widowed 153 39.3
Divorced 33 8.5
Highest level of education
None 80 20.6
Primary 85 21.9
Junior High 159 40.9
Tertiary/Senior High 65 16.7
Occupation
Unemployed 104 26.7
Manual 101 26.0
Clerical/Managerial 12 3.1
Retired 64 16.4
Sales & services 108 27.8
Income level
Less than GH¢500 226 58.1
GHC500–999 99 25.5
GHC1000 and above 64 16.4

Prevalence of OOP payments

The number of respondents who indicated having been asked to make OOP payments at the hospital was 97.2% and the remaining 2.8% indicated that they did not make any OOP payments. This is illustrated in Fig 1 below.

Fig 1. Proportion of respondents who made OOP payments.

Fig 1

Socio-demographic factors associated with making OOP payments

More females (82.8%) made OOP payments than males (17.2%). Additionally, only 6.1% of respondents who made OOP payments were less than 50 years old, with the rest aged 50 years and above. Similarly, a greater proportion (93.9%) of those who made OOP payments were Christians. With respect to marital status, almost half (45%) of the respondents who made OOP payments were married. Further, only 20.4% of those who made OOP payments had no form of education, with the rest having some education. With regards to occupation, 26.7% of those who made OOP payments were unemployed and the rest were in some form of employment. Based on the amount of income earned, more than half (58.2%) of the respondents who made OOP payments earned less than GHC500.00 (equivalent of USD70.13) as monthly income and the rest earned GHC500.00 (USD70.13) and above. In addition, 61.1% of the respondents who made OOP payments visit the hospital every two months. A significant association was found between religion of respondents and making OOP payments (χ2=7.69, p = 0.006), (see Table 2).

Table 2. Socio-demographic characteristics associated with OOP payments.

Variables No OOP payments(%) Made OOP payments(%) Chi2 (p-value)
Age (in years)
<50 0(0.0) 23(6.1) 6.52(0.141)**
50-59 0(0.0) 100(26.5)
60-69 6(54.5) 103(27.2)
70-79 3(27.3) 86(22.7)
80+ 2(18.2) 66(17.5)
Sex
Male 4(36.4) 65(17.2) 2.69(0.112)**
Female 7(63.6) 313(82.8)
Religion
Christianity 8(72.7) 355(93.9) 7.69(0.006)*
Islam 3(27.3) 23(6.1)
Marital status
Separated/Never married 0(0.0) 29(7.7) 3.68(0.495)**
Married 4(36.4) 170(45.0)
Widowed 7(63.6) 146(38.6)
Divorced 0(0.0) 33(8.7)
Highest level of education
None 3(27.3) 77(20.4) 4.36(0.184)**
Primary 2(18.2) 83(22.0)
Junior High 2(18.2) 157(41.5)
Tertiary/Senior High 4(36.4) 61(16.1)
Occupation
Unemployed 3(27.3) 101(26.7) 9.02(0.061)**
Agriculture/Manual 2(18.2) 99(26.2)
Clerical/Managerial 2(18.2) 10(2.7)
Retired 2(18.2) 62(16.4)
Sales & services 2(18.2) 106(28.0)
Income level
Less than GHC500 6(54.5) 220(58.2) 0.06(0.970)**
GHC500–999 3(27.3) 96(25.4)
GHC1000 and above 2(18.2) 62(16.4)
Frequency of hospital attendance
Weekly/fortnight 0(0.0) 10(2.7) 0.33(1.000)**
Monthly 2(18.2) 74(19.6)
Every two months 7(63.6) 231(61.1)
Three months and above 2(18.2) 63(16.7)

* Statistically significant at a p-value< 0.05.

** Fisher’s exact.

OOP payments among respondents

Table 3 presents details on the OOP payments made by respondents in accessing healthcare. A greater proportion of the respondents (97.1%) who had made OOP payments indicated that they made OOP payments in relation to drugs that they were given, 7.4% reportedly made OOP payments in accessing laboratory services, 2.4% each with regards to X-ray and OPD services and 3.7% made these payments in accessing other services. A greater proportion (93.4%) of respondents who made OOP payments paid less than GHC50 (USD7.01), 3.4% and 3.2% made payments between GHC50 (USD7.01) to GHC99 (USD13.88) and GHC100 (USD14.03) to GHC199 (USD27.91) respectively. More than half of the study participants (57.7%) indicated that the monies they used to cover OOP costs were from personal savings, 38.6% reported that their children provided them with the money, 6.6% indicated that it was their partners and 2.9% indicated that their family members provided them with the money that they used to make OOP payments. In addition, 29.1% of those who made OOP payments indicated that they had difficulties in their willingness and ability to make the payments and 70.9% of those who made OOP payments indicated that they had no difficulty making the payments.

Table 3. OOP payments among respondents.

Variable Frequency (n = 378) Percent (%)
Service for which patient made OOP payments
OPD services 9 2.4
Drugs 368 97.1
Laboratory service 28 7.4
X-ray 9 2.4
Others 14 3.7
OOP amount
Less than GHC50 353 93.4
GHC50- GHC99 13 3.4
GHC100- GHC199 12 3.2
Source of funding for OOP payments
Self 218 57.7
Partner 25 6.6
Children 146 38.6
Family members 11 2.9
Difficulty making OOP payments
Yes 110 29.1
No 268 70.9

Reasons for making OOP payments

Fig 2 illustrates the views of the respondents on the reasons why they made OOP payments despite being subscribers to NHIS. More than half (74.6%) of respondents expressed ignorance as to the reasons why they had to make extra payments, 6.4% of respondents reported that it was due to low insurance coverage and 19.1% indicated that it was due to shortage of drugs.

Fig 2. Reasons for making OOP payments.

Fig 2

Self-reported effects of OOP payments on respondents

Table 4 presents the self-reported effects of OOP payments on respondents. A greater proportion of the survey respondents (84.1%) reported that they had never had to borrow money to pay hospital bills and 15.9% of them indicated that they had borrowed money. More than half (79.0%) of the respondents who had ever borrowed money to be able to pay hospital bills indicated that they borrowed less than GHC50 (USD7.01), 11.3% of them borrowed amounts between GHC50 (USD7.01) to GHC99 (13.88) and 9.7% borrowed amounts between GHC100 (USD14.03) to GHC199 (USD27.91). With respect to OOP payments limiting financial abilities concerning other expenses, 71.5% of the survey respondents noted that OOP payments did not limit their financial ability concerning other expenses and 28.5% reported that OOP payments indeed limited their financial abilities concerning other expenses. The respondents who affirmed that OOP payments limited their financial abilities indicated food, clothing, rent, business capital and utility bills as some of the items that were negatively affected by their making OOP payments at the point of accessing health care.

Table 4. Self-reported effects of OOP payments by study participants.

Variable Frequency (n = 389) Percent (%)
Ever borrowed money to attend hospital
Yes 62 15.9
No 327 84.1
Amount of money borrowed to attend hospital
Less than GHC50 49 79.0
GHC50- GHC99 7 11.3
GHC100- GHC199 6 9.7
OOP payments limiting financial ability
Yes 111 28.5
No 278 71.5
Does OOP payments influence hospital attendance
Yes 80 20.6
No 209 79.4
Effect of OOP payments on subsequent hospital visit
No change in hospital attendance 306 78.6
Anxious about next hospital visit 10 2.6
Reluctant to visit hospital 68 17.5
Not come to the hospital again 5 1.3
Self-reported effect of OOP payments on hypertension
Worsened condition 35 9.0
No effect on condition 354 91.0
Alternative means of managing hypertension
Yes 73 18.8
No 316 81.2

More than half of the study respondents (78.6%) indicated that their hospital attendance was not affected by the OOP payments that they were made to pay thus reported no change in hospital attendance and 21.4% of the participants reported that the OOP payments made them either anxious or reluctant about their next visit to the hospital with some reporting that the OOP payments made them not to attend the hospital again as presented in Table 3.

With regards to whether the thought of making extra payments influenced their hospital attendance, a greater proportion of respondents (79.4%) indicated that OOP payments did not influence their hospital attendance and 20.6% indicated that hospital attendance was influenced by OOP payments. In addition, a greater proportion of study participants (90.0%) indicated that OOP payments had no effect on the management of their conditions based on their perspective and 9.0% reported that OOP payments worsened their condition.

With regards to having alternative treatment plans for managing hypertension, more than half of the study participants (81.2%) indicated the scheduled hospital visits as their and 18.8% indicated that they had alternative means of managing hypertension. The common alternative means the respondents mentioned were herbs (see Table 4).

Multivariable analysis of factors influencing difficulty in making OOP payments

Table 5 presents factors influencing difficulty in making OOP payments. Marital status was the only socio-demographic factor that was significantly associated with having difficulty in making OOP payments before adjustment. Married hypertensive patients subscribed to the NHIS were 61% less likely to have difficulty in making OOP payments compared to non-married hypertensive patients (cOR= 0.39; 95% CI: 0.17–0.88; p = 0.023). Respondents for whom OOP payments limited their financial ability in terms of other expenditure were three times more likely to have difficulty in making OOP payments than those that OOP payments did not limit their financial ability before adjustment (cOR=3.13; 95% CI: 1.95–5.03; p < 0.001).

Table 5. Factors associated with difficulty in making OOP payments.

Variable Difficulty in making OOP payments cOR(95% CI) p-value aOR(95% CI) p-value
No (%) Yes (%)
Background characteristics
Age (in years)
<50 16(6.0) 7(6.4) Ref
50-59 74(27.6) 26(23.6) 0.80(0.30,2.17)0.666
60-69 71(26.5) 32(29.1) 1.03(0.39,2.75)0.953
70-79 52(19.4) 34(30.9) 1.49(0.56,4.01)0.425
80+ 55(20.5) 11(10.0) 0.46(0.15,1.37)0.163
Sex
Female 218(81.3) 95(86.4) Ref
Male 50(18.7) 15(13.6) 0.69(0.37,1.29)0.242
Religion
Christianity 245(91.4) 110(100.0)
Islam 23(8.6) 0(0.0) Omitted
Marital status
Separated/Never married 16(6.0) 13(11.8) Ref Ref
Married 129(48.1) 41(37.3) 0.39(0.17,0.88)0.023* 0.63(0.25,1.58)0.321
Widowed 105(39.2) 41(37.3) 0.48(0.21,1.09)0.078 0.67(0.27,1.71)0.405
Divorced 18(6.7) 15(13.6) 1.03(0.38,2.80)0.961 0.85(0.27,2.65)0.778
Highest level of education
None 56(20.9) 21(19.1) Ref
Primary 64(23.9) 19(17.3) 0.79(0.39,1.62)0.523
Junior High 98(36.6) 59(53.6) 1.61(0.88,2.92)0.120
Tertiary/Senior High 50(18.7) 11(10.0) 0.59(0.26,1.34)0.204
Occupation
Unemployed 75(28.0) 26(23.6) Ref
Agriculture/Manual/ 64(23.9) 35(31.8) 1.58(0.86,2.90)0.141
Clerical/Managerial 10(3.7) 0(0.0) 1
Retired 40(14.9) 22(20.0) 1.59(0.80,3.15)0.187
Sales & services 79(29.5) 27(24.6) 0.99(0.53,1.84)0.964
Form of income earned
Cash & kind 92(34.3) 41(37.3) Ref
Cash only 66(24.6) 31(28.2) 1.05(0.60,1.85)0.855
In kind only 12(4.5) 8(7.3) 1.50(0.57,3.94)0.414
Not paid 98(36.6) 30(27.3) 0.69(0.40,1.19)0.181
Income level
Less than GHC500 158(59.0) 62(56.4) Ref
GHC500–999 66(24.6) 30(27.3) 1.16(0.69,1.95)0.581
GHC1000 and above 44(16.4) 18(16.3) 1.04(0.56,1.94)0.896
Contextual characteristics
Amount of OOP cost paid
Less than GHC50 255(95.2) 98(89.1) Ref
GHC50–99 7(2.6) 6(5.5) 2.23(0.73,6.80)0.159
GHC100–199 6(2.2) 6(5.5) 2.60(0.82,8.26)0.105
Ever borrowing money to cover health expense
No 234(87.3) 82(74.6) Ref Ref
Yes 34(12.7) 28(25.5) 2.35(1.34,4.11)0.003* 2.52(1.31,4.88)0.006*
OOP payments limiting financial ability
No 210(78.4) 59(53.6) Ref Ref
Yes 58(21.6) 51(46.4) 3.13(1.95,5.03)<0.001* 0.90(0.46,1.76)0.761
OOP payments influencing hospital attendance
No 237(88.4) 61(55.5) Ref Ref
Yes 31(11.6) 49(44.6) 6.14(3.61,10.44)<0.001* 5.52(2.74,11.11)<0.001*
Alternative form of treating hypertension
No 231(86.2) 76(69.1) Ref Ref
Yes 37(13.8) 34(30.9) 2.79(1.64,4.76)<0.001* 2.93(1.60,5.38)0.001*

* Statistically significant at p < 0.05.

After adjustments, ever borrowing money to cover health expenses, OOP payments affecting hospital attendance and having an alternative form of treating hypertension were significantly associated with having difficulty making OOP payments. The respondents who had ever borrowed money to cover health expenses were two times more likely to have difficulty in making OOP payments compared to participants who had never borrowed money to cover their health expenses (aOR=2.52; 95% CI: 1.31–4.88; p = 0.006).

Additionally, respondents who indicated that OOP payments influenced their hospital attendance were five times more likely to have difficulty in making OOP payments compared to those for whom OOP payments had no influence on their hospital attendance (aOR=5.52; 95% CI: 2.74–11.11; p < 0.001) and study participants who had an alternative method of treating hypertension such as herbs were twice more likely to have a difficulty in making OOP payments than those who did not have any other method of treating hypertension apart from scheduled hospital visits (aOR=2.93; 95% CI: 1.60–5.38; p = 0.001), (see Table 5).

Discussion

This study sought to measure OOP payments among hypertensive patients insured under the NHIS. Our results observed a significantly higher prevalence of OOP payments in Ghana as compared to a previous study in the country [8]. This may be explained by the homogenous nature of our respondents which is further confirmed by another homogenous study on maternal health which reported similar prevalence of OOP payments as our findings [31]. Based on the results of this study, 97.2% of study respondents made OOP payments to access healthcare services and 2.8% did not make any OOP payments. This is corroborated by a previous study which reported a 93.6% OOP expense incurred as a result of seeking healthcare for hypertension in a low-income urban part of Columbia [32]. These results imply that managing hypertension is costly. Although 93.4% of the respondents paid amounts less than GHC50 (USD7.01), it is important that this is not discounted. This is because based on the socio-demographic characteristics of the respondents in this study, the average age was 66 years, almost half of them (43.1%) were either retired or unemployed, 58.1% earned income below GHC500.00 (USD70.13) monthly and were required to attend scheduled periodic hospital reviews thereby incurring further costs. Our findings are reiterated by a study in Ghana which emphasized that having health insurance albeit important, may not provide adequate financial protection for the poor [22].

A similar study also revealed that no single individual had zero OOP expense although the authors suggest that OOP expenditure is reduced considerably by having insurance [33]. Results from a similar study also confirm that OOP payments are fast becoming a reality on all kinds of health services including those covered by insurance for both in-patient and out-patient services [2]. In Taiwan, research has identified that the country’s National Health Insurance system successfully reduced household OOP payments by about 23% though it could not fully ease the financial distress caused by sickness with households in the lower- and middle-income quintiles experiencing only minimal reductions in OOP payments [34] and in Nigeria, activism for OOP health expenditure has relented as proponents agree that it negatively affects the poor [35].

Based on the findings of this study, drugs alone accounted for 97.1% of health services on which patients made OOP payments. This finding is corroborated by a previous study which indicated that pharmaceuticals make up a significant proportion of healthcare expenditure in many countries [34]. Another study in Peru revealed that a greater proportion of incurred OOP expenditure was attributable to medications [36]. This is confirmed by research in Chile which indicated that drugs are the major components of OOP payments [37]. This is consistent with another research on maternal health in northern Ghana which established that patients made OOP payments as a result of drug stock-outs [38]. Another study indicated that OOP payments were attributable to shortage of prescribed drugs or prescription of drugs not on the NHIS drug list and this was as a result of constant delays in reimbursement by the NHIS to health service providers invariably leading to either periodic shortages or refusal of service providers to provide NHIS subscribers with the needed drugs [8].

Data gathered in this study revealed that laboratory services accounted for 7.4% of OOP payments with X-ray and OPD services accounting for 2.4% each. In essence, OOP payments and the resultant financial burden differ with respect to the type of health service utilized with more than 92% of those who access out-patient services at private health facilities spending money on OOP payments and about 70% of attendants of public health facilities spending on OOP costs related to in-patient care services and a considerably larger percentage in cases of surgery [39]. In Bangladesh, research has identified that the average cost of disease-specific OOP payments was considerably higher in cases of chronic illnesses [40].

Based on the results of the study, 29.1% of the survey respondents who had made OOP payments expressed difficulty in their willingness and ability to make OOP payments. Overall, this study did not find significant association between difficulty in making OOP payments and socio-demographic factors except marital status before adjustment. A similar study on maternal health in Ghana however established that women from low neighbourhood disadvantage levels had a higher prevalence of OOP payment [18].

A factor that influenced difficulty in making OOP payments was ever borrowing money to cover health expenses as results from the survey respondents indicated. Respondents who had ever borrowed money to cover health expenses were two times more likely to have difficulty in making OOP payments compared to participants who had never borrowed money to cover their health expense. This is consistent with findings from a study in Zambia which established that persons who were faced with unaffordable OOP payments experienced hardship financing which was characterized by borrowing money for healthcare [41]. A similar study in Cambodia revealed that the households incurred an average of US$125 due to borrowing in order to access healthcare and experienced hardship financing [42].

In this study, respondents for whom OOP payments limited their financial ability in terms of other expenditure were three times more likely to have difficulty in making OOP payments than those that OOP payments did not limit their financial ability before adjustment. This is consistent with findings on SSA which reported that OOP payment is associated with household financial burdens [43]. Additionally, the study revealed an association between OOP payments influence on hospital attendance and difficulty in making OOP payments as survey respondents who indicated that OOP payments influenced their hospital attendance were five times more likely to have difficulty in making OOP payments compared to those for whom OOP payments had no influence on their hospital attendance.

Based on results from this study, survey respondents who had an alternative method of treating hypertension such as herbs were twice more likely to have a difficulty in making OOP payments than those who did not have any other method of treating hypertension apart from scheduled hospital visits. Research has reported that alternative forms of treatment such as home treatment has an effect on OOP payments [44].

OOP payments influenced the hospital attendance of 20.6% of the survey respondents as confirmed by research in Taiwan which indicated that prospective patients forego needed treatment and preventive care services due to high OOP expenditure resulting in negative clinical consequences [34]. This is also consistent with a similar study in Iran which reported that patients forego healthcare due to OOP payments [45].

A number of hypertensive patients recruited for the study admitted that they had alternative means of managing their condition with the recurring alternative being the use of local herbs. The study also revealed that 9% of the study respondents reported that OOP payments resulted in their conditions becoming worsened which is corroborated by a study which revealed that high OOP payments on prescription drugs is related with a higher rate of adverse outcomes and hospital emergency unit visits among the aged and welfare beneficiaries [34]. Research suggests that while some OOP payments are related to essential medical treatments, certain other OOP payments are not dire for improving health status [34]. An examination of poverty consequences of healthcare spending indicates an upward trend of medical impoverishment resulting in great concern for policy makers and other stakeholders [39].

Strengths and limitations

This was a comprehensive study that showed the prevalence of OOP payments, reasons for such payments and the self-reported effects of OOP payments among hypertensive patients who are subscribed to the NHIS. The current study provides useful insights based on the individuals’ perspectives and adds to existing literature on OOP payments.

Our study, however, has some limitations which must be acknowledged. We employed a cross-sectional study design which did not demonstrate the cause-and-effect relationship between the dependent and independent variables but only determined associations. Additionally, this type of study only examined the current situation and may ignore changes over time. Also, our study did not distinguish between authorised and unauthorised payments. While we clarified the operational definition of payments during data collection, we acknowledge that self-reported payments may still be subject to recall bias and variability in interpretation. This could lead to misinterpretation of the data and as such, results should be interpreted with caution.

Further, the article does not fully assess the impact of OOP payments on the economic situation of households, especially poor households, which is essential to achieving the SDGs. Furthermore, the sample was drawn from only the Volta Region, which may not be representative of the entire country. Similarly, our findings were based on self-reported data which may lead to inaccuracies due to certain biases such as recall and social desirability. To address this, respondents were assured of anonymity and confidentiality. The facility-based nature of the study also minimized recall bias since respondents were interviewed immediately after having accessed health services. Sensitivity analyses were not conducted for the logistic regression models due to the distribution of the outcome variables.

These limitations should be considered when interpreting the findings and highlight opportunities for further research to address these gaps.

Conclusion

OOP payments have financial consequences on households and with a remarkably high burden of OOP payments among hypertensive patients subscribed to the NHIS as observed by our study, there is the need to remain vigilant in ensuring that the targets of SDG 3 are attained in Ghana. To address the issue of payment for drugs covered under NHIS, the National Health Insurance Authority (NHIA) must ensure that drugs and services which are covered by the NHIS are available to all subscribers. Specifically essential medicines for controlling CNCDs must be made available as mandated under the NHIS and made accessible to those who need them in line with SDG 3.4. Based on this, the NHIA must address periodic drug stock-outs of medicines which hospitals face to ensure that healthcare seekers, especially hypertensive patients, have access to the right medications for their conditions. Periodic monitoring at health facilities must be undertaken by the NHIA to ensure that the scheme’s mandate of attaining UHC in Ghana is achieved and any loopholes addressed. The government through the Ministry of Health must strengthen the NHIS, which is the tool for attaining UHC, to ensure that it delivers its mandate. It is also recommended that studies which determine the differences in OOP payments between insured and uninsured patients be conducted to estimate the level of financial protection the NHIS affords its active members.

Supporting information

S1 File. Dataset_outofpocketpayments.

(XLSX)

pone.0348971.s001.xlsx (53.1KB, xlsx)

Acknowledgments

The completion of this work was possible thanks to the support of several people, to whom we take this opportunity to express our gratitude. Thus, we would like to express our gratitude to the management of the Volta Regional Hospital, Hohoe and the staff of the hypertensive clinic. We would also like to thank all the respondents for their time.

Abbreviations

CNCD

Chronic non-communicable disease

CVD

Cardiovascular disease

LMIC

Low-and middle-income country

NCD

Non-communicable disease

NHIA

National Health Insurance Authority

NHIS

National Health Insurance Scheme

O&G

Obstetrics and Gynaecology

OOP

Out-of-pocket

OPD

Out-patient-department

PI

Principal Investigator

REC

Research Ethics Committee

SDG

Sustainable Development Goal

SSA

Sub-Saharan Africa

UHAS

University of Health and Allied Sciences

UHC

Universal Health Coverage

WHO

World Health Organization

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Thomson S, CJ, ET. Can people afford to pay for health care? New evidence on financial protection in Europe. Regional Office for Europe: World Health Organization. 2019. [Google Scholar]
  • 2.Aryeetey GC, Westeneng J, Spaan E, Jehu-Appiah C, Agyepong IA, Baltussen R. Can health insurance protect against out-of-pocket and catastrophic expenditures and also support poverty reduction? Evidence from Ghana’s National Health Insurance Scheme. Int J Equity Health. 2016;15(1):116. doi: 10.1186/s12939-016-0401-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Ebaidalla EM, Ali MEM. Determinants and impact of household’s out-of-pocket healthcare expenditure in Sudan: evidence from urban and rural population. Middle East Development Journal. 2019;11(2):181–98. doi: 10.1080/17938120.2019.1668163 [DOI] [Google Scholar]
  • 4.Ministry of Health. National Health Insurance Policy Framework. 2004. [Google Scholar]
  • 5.Wang H, Otoo N, Dsane-Selby L. Ghana National Health Insurance Scheme: Improving Financial Sustainability Based on Expenditure Review. 2017. doi: 10.1596/978-1-4648-1117-3 [DOI] [Google Scholar]
  • 6.Umar S, Fusheini A, Ayanore MA. The shared experiences of insured members and the uninsured in health care access and utilization under Ghana’s national health insurance scheme: Evidence from the Hohoe Municipality. PLoS One. 2020;15(12):e0244155. doi: 10.1371/journal.pone.0244155 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Okoroh J, Essoun S, Seddoh A, Harris H, Weissman JS, Dsane-Selby L, et al. Evaluating the impact of the national health insurance scheme of Ghana on out of pocket expenditures: a systematic review. BMC Health Serv Res. 2018;18(1):426. doi: 10.1186/s12913-018-3249-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Akweongo P, Aikins M, Wyss K, Salari P, Tediosi F. Insured clients out-of-pocket payments for health care under the national health insurance scheme in Ghana. BMC Health Serv Res. 2021;21(1):440. doi: 10.1186/s12913-021-06401-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Swetha NB, Shobha S, Sriram S. Prevalence of catastrophic health expenditure and its associated factors, due to out-of-pocket health care expenses among households with and without chronic illness in Bangalore, India: a longitudinal study. J Prev Med Hyg. 2020;61(1):E92–7. doi: 10.15167/2421-4248/jpmh2020.61.1.1191 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.World Health Organization. Noncommunicable diseases fact sheet. 2021. https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases
  • 11.Dosoo DK, Nyame S, Enuameh Y, Ayetey H, Danwonno H, Twumasi M, et al. Prevalence of Hypertension in the Middle Belt of Ghana: A Community-Based Screening Study. Int J Hypertens. 2019;2019:1089578. doi: 10.1155/2019/1089578 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Bosu WK, Bosu DK. Prevalence, awareness and control of hypertension in Ghana: A systematic review and meta-analysis. PLoS One. 2021;16(3):e0248137. doi: 10.1371/journal.pone.0248137 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Dai B, Addai-Dansoh S, Nutakor JA, Osei-Kwakye J, Larnyo E, Oppong S, et al. The prevalence of hypertension and its associated risk factors among older adults in Ghana. Front Cardiovasc Med. 2022;9:990616. doi: 10.3389/fcvm.2022.990616 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Amu H, Darteh EKM, Tarkang EE, Kumi-Kyereme A. Management of chronic non-communicable diseases in Ghana: a qualitative study using the chronic care model. BMC Public Health. 2021;21:1–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Salari P, Akweongo P, Aikins M, Tediosi F. Determinants of health insurance enrolment in Ghana: evidence from three national household surveys. Health Policy Plan. 2019;34(8):582–94. doi: 10.1093/heapol/czz079 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Laar AK, Adler AJ, Kotoh AM, Legido-Quigley H, Lange IL, Perel P, et al. Health system challenges to hypertension and related non-communicable diseases prevention and treatment: perspectives from Ghanaian stakeholders. BMC Health Serv Res. 2019;19(1):693. doi: 10.1186/s12913-019-4571-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Sanuade OA, Boatemaa S, Kushitor MK. Hypertension prevalence, awareness, treatment and control in Ghanaian population: Evidence from the Ghana demographic and health survey. PLoS One. 2018;13(11):e0205985. doi: 10.1371/journal.pone.0205985 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Ekholuenetale M, Barrow A. Inequalities in out-of-pocket health expenditure among women of reproductive age: after-effects of national health insurance scheme initiation in Ghana. J Egypt Public Health Assoc. 2021;96(1):6. doi: 10.1186/s42506-020-00064-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Nemati E, Khezri A, Nosratnejad S. The Study of Out-of-pocket Payment and the Exposure of Households with Catastrophic Health Expenditures Following the Health Transformation Plan in Iran. Risk Manag Healthc Policy. 2020;13:1677–85. doi: 10.2147/RMHP.S264943 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.The 17 goals | Sustainable development. https://sdgs.un.org/goals
  • 21.Targets of Sustainable Development Goal 3. https://www.who.int/europe/about-us/our-work/sustainable-development-goals/targets-of-sustainable-development-goal-3
  • 22.Sataru F, Twumasi-Ankrah K, Seddoh A. An Analysis of Catastrophic Out-of-Pocket Health Expenditures in Ghana. Front Health Serv. 2022;2:706216. doi: 10.3389/frhs.2022.706216 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Okoroh J, Sarpong DO-B, Essoun S, Riviello R, Harris H, Weissman JS. Does insurance protect individuals from catastrophic payments for surgical care? An analysis of Ghana’s National Health Insurance Scheme at Korle-Bu teaching Hospital. BMC Health Serv Res. 2020;20(1):45. doi: 10.1186/s12913-020-4887-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Agyepong IA, Abankwah DNY, Abroso A, Chun C, Dodoo JNO, Lee S, et al. The “Universal” in UHC and Ghana’s National Health Insurance Scheme: policy and implementation challenges and dilemmas of a lower middle income country. BMC Health Serv Res. 2016;16(1):504. doi: 10.1186/s12913-016-1758-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Egger M, Altman DG, Vandenbroucke JP, of the STROBE group. Commentary: strengthening the reporting of observational epidemiology the STROBE statement. Int J Epidemiol. 2007;36(5):948–50. doi: 10.1093/ije/dym199 [DOI] [PubMed] [Google Scholar]
  • 26.Mann CJ. Observational research methods. Research design II: cohort, cross sectional, and case-control studies. Emerg Med J. 2003;20(1):54–60. doi: 10.1136/emj.20.1.54 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.HMHD. Hohoe Municipal Health Directorate Annual Report. 2021. [Google Scholar]
  • 28.Ministry of Health. National Health Policy. 2020. [Google Scholar]
  • 29.Cochran WG. Sampling techniques. 3rd ed. New York: John Wiley & Sons. 1977. [Google Scholar]
  • 30.Exchange Rate – Bank of Ghana. https://www.bog.gov.gh/economic-data/exchange-rate/
  • 31.Alatinga KA, Abiiro GA, Kanmiki EW, Gyan EK, Hsu V, Moyer CA. Burden of out-of-pocket payment for maternal healthcare and its catastrophic effects in the era of free maternal and child health policy in Ghana. SSM - Health Systems. 2024;3:100018. doi: 10.1016/j.ssmhs.2024.100018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Londoño Agudelo E, García Fariñas A, Pérez Ospina V, Taborda Pérez C, Villacrés Landeta T, Battaglioli T, et al. Out-of-pocket expenditure for hypertension care: a population-based study in low-income urban Medellin, Colombia. Glob Health Action. 2020. doi: 10.1080/16549716.2020.1806527 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Thanh ND, Anh BTM, Xiem CH, Van Minh H. Out-of-Pocket Health Expenditures Among Insured and Uninsured Patients in Vietnam. Asia Pac J Public Health. 2019;31(3):210–8. doi: 10.1177/1010539519833549 [DOI] [PubMed] [Google Scholar]
  • 34.Ku Y-C, Chou Y-J, Lee M-C, Pu C. Effects of National Health Insurance on household out-of-pocket expenditure structure. Soc Sci Med. 2019;222:1–10. doi: 10.1016/j.socscimed.2018.12.010 [DOI] [PubMed] [Google Scholar]
  • 35.Aregbeshola BS, Khan SM. Out-of-Pocket Payments, Catastrophic Health Expenditure and Poverty Among Households in Nigeria 2010. Int J Health Policy Manag. 2018;7:798–806. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Proaño Falconi D, Bernabé E. Determinants of catastrophic healthcare expenditure in Peru. Int J Health Econ Manag. 2018;:10.1007/s10754-018-9245–0. doi: 10.1007/s10754-018-9245-0 [DOI] [PubMed] [Google Scholar]
  • 37.Villalobos Dintrans P. Out-of-pocket health expenditure differences in Chile: Insurance performance or selection?. Health Policy. 2018;122(2):184–91. doi: 10.1016/j.healthpol.2017.11.007 [DOI] [PubMed] [Google Scholar]
  • 38.Dalinjong PA, Wang AY, Homer CSE. The operations of the free maternal care policy and out of pocket payments during childbirth in rural Northern Ghana. Health Econ Rev. 2017;7(1):41. doi: 10.1186/s13561-017-0180-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Sisira Kumara A, Samaratunge R. Relationship between healthcare utilization and household out-of-pocket healthcare expenditure: Evidence from an emerging economy with a free healthcare policy. Soc Sci Med. 2019;235:112364. doi: 10.1016/j.socscimed.2019.112364 [DOI] [PubMed] [Google Scholar]
  • 40.Rahman MM, Zhang C, Swe KT, Rahman MS, Islam MR, Kamrujjaman M, et al. Disease-specific out-of-pocket healthcare expenditure in urban Bangladesh: A Bayesian analysis. PLoS One. 2020;15(1):e0227565. doi: 10.1371/journal.pone.0227565 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Kaonga O, Banda C, Masiye F. Hardship financing of out-of-pocket payments in the context of free healthcare in Zambia. PLoS One. 2019;14(4):e0214750. doi: 10.1371/journal.pone.0214750 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Ir P, Jacobs B, Asante AD, Liverani M, Jan S, Chhim S, et al. Exploring the determinants of distress health financing in Cambodia. Health Policy Plan. 2019;34(Supplement_1):i26–37. doi: 10.1093/heapol/czz006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Kiross GT, Chojenta C, Barker D, Loxton D. The effects of health expenditure on infant mortality in sub-Saharan Africa: evidence from panel data analysis. Health Econ Rev. 2020;10(1):5. doi: 10.1186/s13561-020-00262-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Abor PA, Abor JY. Implications of COVID-19 Pandemic for Health Financing System in Ghana. Journal of Health Management. 2020;22(4):559–69. doi: 10.1177/0972063420983096 [DOI] [Google Scholar]
  • 45.Gharibi F, Imani A, Dalal K. The catastrophic out-of-pocket health expenditure of multiple sclerosis patients in Iran. BMC Health Serv Res. 2021;21(1):257. doi: 10.1186/s12913-021-06251-4 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Miquel Vall-llosera Camps

25 Apr 2025

-->PONE-D-25-08305-->-->Out-of-pocket payments and associated factors among hypertensive patients insured under the National Health Insurance Scheme in a referral hospital, Ghana-->-->PLOS ONE

Dear Dr. Ackon,

Thank you for submitting your manuscript to PLOS One. Firstly, we would like to apologize for the delay in processing your manuscript. It has been exceptionally difficult to secure reviewers to evaluate your study. We have now received one completed review, which is available below. The reviewer has raised significant scientific concerns about the study that need to be addressed in a revision.

Please note that we have only been able to secure a single reviewer to assess your manuscript. We are issuing a decision on your manuscript at this point to prevent further delays in the evaluation of your manuscript. Please be aware that the editor who handles your revised manuscript might find it necessary to invite additional reviewers to assess this work once the revised manuscript is submitted. However, we will aim to proceed on the basis of this single review if possible.

Please submit your revised manuscript by Jun 08 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:-->

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Miquel Vall-llosera Camps

Senior Staff Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that Figure 1 in your submission contain [map/satellite] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

1. You may seek permission from the original copyright holder of Figure 1 to publish the content specifically under the CC BY 4.0 license.

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

2. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/

The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/

Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html

NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/

Landsat: http://landsat.visibleearth.nasa.gov/

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#

Natural Earth (public domain): http://www.naturalearthdata.com/

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

-->Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. -->

Reviewer #1: Partly

**********

-->2. Has the statistical analysis been performed appropriately and rigorously? -->

Reviewer #1: Yes

**********

-->3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #1: Yes

**********

-->4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.-->

Reviewer #1: No

**********

-->5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)-->

Reviewer #1: Dear author, thank you for your manuscript. The following comments are sent to enrich your work

It is better to focus more on the main challenge in the introduction and avoid additional explanations. State the main reason for choosing this topic and its importance.

State the time frame of the research.

Abbreviation for out-of-pocket payments is OOP not OPP.

The use of a cross-sectional method may not be able to show the cause-and-effect relationship between factors related to out-of-pocket payments. This type of study only examines the current situation and may ignore changes over time

This article does not provide a precise definition of "out-of-pocket payments" and does not distinguish between authorized and unauthorized payments. This could lead to misinterpretation of the data.

The sample was drawn from only three regions, which may not be representative of the entire country. This makes it difficult to generalize the results to other regions of Ghana.

The article does not fully assess the impact of out-of-pocket payments on the economic situation of households, especially poor households, which is essential to achieving the Sustainable Development Goals.

The article does not provide a precise definition of “out-of-pocket payments” and does not distinguish between authorized and unauthorized payments. This can lead to misinterpretation of the data.

Although the article provides recommendations, it does not provide practical solutions for implementing these recommendations.

**********

-->6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.-->

Reviewer #1: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Dear author.docx

pone.0348971.s002.docx (14.5KB, docx)
PLoS One. 2026 May 14;21(5):e0348971. doi: 10.1371/journal.pone.0348971.r002

Author response to Decision Letter 1


28 May 2025

University of Health and Allied Sciences

Fred N. Binka School of Public Health

PMB 31, Ho

May 28, 2025

The Editor-in-Chief

Plos One

Dear Dr. Camps,

Subject: Response to Reviewers for Manuscript [PONE-D-25-08305]

I sincerely appreciate the time and effort that you and the reviewer have invested in evaluating our manuscript, titled “Out-of-pocket payments and associated factors among hypertensive patients insured under the National Health Insurance Scheme in a referral hospital, Ghana”. We are grateful for the constructive feedback, which has helped us improve the quality and clarity of our work.

Below, we provide detailed responses to the editor and reviewer’s comments. We have carefully revised the manuscript to address all concerns and believe that the updated version strengthens our study.

Journal requirements:

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming.

Response: Thank you for pointing this out. We have thoroughly reviewed the journal’s submission guidelines and revised the paper accordingly. This includes adjustments to section headings, line spacing, abstract format and other formatting specifications.

2. We note that Figure 1 in your submission contain [map/satellite] images which may be copyrighted. We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission.

Response: Thank you for pointing this out. We have removed the figure from the paper to avoid any copyright infringement.

Reviewer #1 comments:

1. Comment: It is better to focus more on the main challenge in the introduction and avoid additional explanations. State the main reason for choosing this topic and its importance.

Response: Thank you for this insightful comment. We appreciate your points on the need to be concise and specific. To improve clarity and focus, we have made major edits for conciseness while retaining key references which directly support the rationale for the research. We believe that this revision strengthens your reading experience by leading to the main reason for choosing this topic and its importance more quickly.

2. Comment: State the time frame of the research.

Response: Thank you for pointing this out. We have revised the manuscript to include the time frame of the research (See Pages 2, 7 & Lines 25, 116)

3. Comment: Abbreviation for out-of-pocket payments is OOP not OPP.

Response: Thank you for noting this. We have revised the entire manuscript to reflect OOP as the appropriate abbreviation for out-of-pocket and not OPP.

4. Comment: The use of a cross-sectional method may not be able to show the cause-and-effect relationship between factors related to out-of-pocket payments. This type of study only examines the current situation and may ignore changes over time.

Response: Thank you for this important point. We agree that cross-sectional studies are not able to determine causality and do not consider changes overtime. We have therefore acknowledged that our adoption of this study design is a key limitation of our study. This acknowledgement enhances the integrity of the paper.

5. Comment: This article does not provide a precise definition of "out-of-pocket payments" and does not distinguish between authorized and unauthorized payments. This could lead to misinterpretation of the data.

Response: Thank you for this insightful comment. We agree that the lack of a clear distinction between authorized and unauthorized out-of-pocket payments may lead to a misrepresentation of our findings. We have therefore acknowledged this as an important limitation of our study. This admission strengthens the transparency and credibility of the paper.

6. Comment: The sample was drawn from only three regions, which may not be representative of the entire country. This makes it difficult to generalize the results to other regions of Ghana.

Response: Thank you for this insightful comment. We agree that our study may not be generalizable to the other regions of Ghana. As such, we have acknowledged this as a major limitation of our study.

7. Comment: The article does not fully assess the impact of out-of-pocket payments on the economic situation of households, especially poor households, which is essential to achieving the Sustainable Development Goals.

Response: Thank you for this important point. We agree that our study did not comprehensively evaluate the impact of out-of-pocket payments on the economic situation of households. We have therefore acknowledged this as a key limitation of our study which we hope strengthens the transparency of the paper.

8. Comment: Although the article provides recommendations, it does not provide practical solutions for implementing these recommendations.

Response: Thank you for noting this. We have expanded our recommendations to include the key stakeholders responsible for implementing the recommendations we gave.

We hope that these revisions satisfactorily address the editor and reviewer’s concerns. We appreciate the opportunity to improve our manuscript and look forward to your feedback.

Thank you for your time and consideration.

Sincerely,

Angela Nana Esi Ackon

angela.aan2009@gmail.com

Attachment

Submitted filename: Response to Reviewers.docx

pone.0348971.s004.docx (21KB, docx)

Decision Letter 1

Charles Ezenduka

20 Feb 2026

-->PONE-D-25-08305R1-->-->Out-of-pocket payments and associated factors among hypertensive patients insured under the National Health Insurance Scheme in a referral hospital, Ghana-->-->PLOS One

Dear Dr. Ackon,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Apr 06 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:-->

  • A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

-->If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Charles C Ezenduka, PhD

Academic Editor

PLOS One

Journal Requirements:

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

The last reviewer has raised a significant and valid concerns that require authors' attention and responses to enhance quality of the manuscript to meet publication criteria.

Hence, authors are requested to respond to these comments based on a minor essential revision

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

-->Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.-->

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

Reviewer #3: All comments have been addressed

**********

-->2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. -->

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

-->3. Has the statistical analysis been performed appropriately and rigorously? -->

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

-->4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

-->5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.-->

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

-->6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)-->

Reviewer #1: Dear Editor,

Hello

I confirm that all the reviewer comments provided to the authors have been fully addressed and incorporated into the revised version of the manuscript. The authors have responded appropriately to each point, and the revisions made adequately reflect the feedback previously given.

Reviewer #2: The revised manuscript provides a timely and policy-relevant analysis of out-of-pocket payments among insured hypertensive patients in Ghana, addressing an important gap in the universal health coverage discourse. The methodology is appropriate, with clear use of cross-sectional design, adequate sample size, and robust multivariable logistic regression analysis. The findings are clearly presented and demonstrate significant associations with meaningful public health implications. The discussion appropriately contextualizes the results within SDG targets and national insurance policy objectives. I recommend acceptance of the manuscript in its current form.

Reviewer #3: General comment

The authors have clearly engaged with the prior reviewer comments and have added explicit limitations, clarified timeframe, corrected terminology, and expanded recommendations. The manuscript is scientifically coherent and addresses an important health-financing question. However, several editorially critical and methodologically relevant issues remain unresolved, including internal inconsistencies, reporting clarity, sampling description accuracy, and analytical interpretation.

Specific comments

1. While the authors state that all instances of OPP were replaced with OOP, the revised manuscript still contains multiple residual “OPPsOOP” artifacts, indicating incomplete editing and typesetting inconsistencies (visible in conclusions and limitations sections).

2. The limitation about not distinguishing authorised vs unauthorised payments is acknowledged, which is good, but the manuscript still does not operationally define how respondents interpreted OOP payments during data collection. This raises interpretability concerns about whether co-payments and informal payments, alongside drug purchases outside facility were included. In essence, the limitation statement remains insufficient as readers need clearer operational framing in the Methods.

3. While the limitation about single-region sampling is properly acknowledged, the reviewer response incorrectly states the sample was from three regions whereas the manuscript clearly describes one facility in the Volta Region. This mismatch should be corrected for consistency.

4. While stakeholder identification has been added to the recommendations, most of the policy recommendations remain generic, with limited linkage to study findings. I recommend that the authors tie each recommendation directly to a specific empirical result.

5. The manuscript states: sample size target = 422 (after non-response adjustment), and actual sample recruited = 389. However, there is no explanation for this discrepancy. This reporting gap could affect reproducibility and transparency. In addition, the randomisation description suggests systematic daily recruitment rather than true simple random sampling, and while a potential repeat-visit bias mitigation is described, it was not validated.

6. While the authors acknowledge that outcome variables rely entirely on self-report, this could be better contextualised along recall bias, misclassification and social desirability bias risks.

7. While the Logistic regression seems appropriate, some missing essentials include variable selection criteria, model diagnostics, multicollinearity checks, and sensitivity analysis. These elements of model transparency would improve rigour.

8. In result interpretation, the prevalence estimate (97.2%) is extremely high relative to cited Ghanaian literature. While the discussion attributes this to sample homogeneity, this explanation is not empirically demonstrated. Thus, the conclusion risks overstating generalisable burden.

9. Several issues require correction as multiple sections contain duplicated or corrupted terms (e.g., OPPsOOP). For instance, percent denominators are sometimes unclear, there are overlapping categories, and Fisher vs Chi-square labelling seem inconsistent.

10. Also, there are some logical phrasing issues such as “findings are important and generalisable”. This is contradicted by the already stated sampling limitations. Again, the claim that findings are generalisable is not sufficiently justified given the single facility, region-specific context, and older patient skew. A revision should reflect analytic relevance, not population generalisability.

11. The revised manuscript does not report any formal robustness or sensitivity analyses beyond the primary logistic regression model. Including some basic model diagnostics or alternative specifications would strengthen confidence in the findings. Given the very high prevalence of OOP payments and reliance on self-reported measures, demonstrating that the main associations are not sensitive to modelling choices would enhance the methodological transparency and credibility of the results.

**********

-->7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.-->

Reviewer #1: No

Reviewer #2: Yes: Dr. Ragni Kumari

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation.

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

-->

PLoS One. 2026 May 14;21(5):e0348971. doi: 10.1371/journal.pone.0348971.r004

Author response to Decision Letter 2


15 Apr 2026

I sincerely appreciate the time and effort that you and the reviewers have invested in evaluating our manuscript, titled “Out-of-pocket payments and associated factors among hypertensive patients insured under the National Health Insurance Scheme in a referral hospital, Ghana”. We are grateful for the constructive feedback, which has helped us improve the quality and clarity of our work.

Below, we provide detailed responses to the editor and reviewers’ comments. We have carefully revised the manuscript to address all concerns and believe that the updated version strengthens our study.

Reviewer #1: Dear Editor,

Hello

I confirm that all the reviewer comments provided to the authors have been fully addressed and incorporated into the revised version of the manuscript. The authors have responded appropriately to each point, and the revisions made adequately reflect the feedback previously given.

Reviewer #2: The revised manuscript provides a timely and policy-relevant analysis of out-of-pocket payments among insured hypertensive patients in Ghana, addressing an important gap in the universal health coverage discourse. The methodology is appropriate, with clear use of cross-sectional design, adequate sample size, and robust multivariable logistic regression analysis. The findings are clearly presented and demonstrate significant associations with meaningful public health implications. The discussion appropriately contextualizes the results within SDG targets and national insurance policy objectives. I recommend acceptance of the manuscript in its current form.

Reviewer #3: General comment

The authors have clearly engaged with the prior reviewer comments and have added explicit limitations, clarified timeframe, corrected terminology, and expanded recommendations. The manuscript is scientifically coherent and addresses an important health-financing question. However, several editorially critical and methodologically relevant issues remain unresolved, including internal inconsistencies, reporting clarity, sampling description accuracy, and analytical interpretation.

Specific comments

1. Comment: While the authors state that all instances of OPP were replaced with OOP, the revised manuscript still contains multiple residual “OPPsOOP” artifacts, indicating incomplete editing and typesetting inconsistencies (visible in conclusions and limitations sections).

Response: Thank you for pointing this out. We have thoroughly revised the entire manuscript and expunged all residual artifacts. We have also ensured consistency in editing across all sections.

2. Comment: The limitation about not distinguishing authorised vs unauthorised payments is acknowledged, which is good, but the manuscript still does not operationally define how respondents interpreted OOP payments during data collection. This raises interpretability concerns about whether co-payments and informal payments, alongside drug purchases outside facility were included. In essence, the limitation statement remains insufficient as readers need clearer operational framing in the Methods.

Response: Thank you for this insightful comment. We have revised the methods to clearly detail how respondents were instructed to interpret payments. Our study however excludes payments made outside of the facility since we sought to examine the out-of-pocket payments made which would have ordinarily been covered by the NHIS. In our revision, we have strengthened the operational definition of payments in the methods section. We believe that these revisions would enhance transparency (See Page 9, Lines 164-173).

3. Comment: While the limitation about single-region sampling is properly acknowledged, the reviewer response incorrectly states the sample was from three regions whereas the manuscript clearly describes one facility in the Volta Region. This mismatch should be corrected for consistency.

Response: Thank you for this important observation. We acknowledge that our sample was drawn from one facility in the Volta region and hence our response to the previous review comment should have clarified the absence of any mention of three regions in our manuscript.

4. Comment: While stakeholder identification has been added to the recommendations, most of the policy recommendations remain generic, with limited linkage to study findings. I recommend that the authors tie each recommendation directly to a specific empirical result.

Response: Thank you for this insightful comment. We have revised the recommendations to relate it more closely with the results to enhance their practical relevance.

5. Comment: The manuscript states: sample size target = 422 (after non-response adjustment), and actual sample recruited = 389. However, there is no explanation for this discrepancy. This reporting gap could affect reproducibility and transparency. In addition, the randomisation description suggests systematic daily recruitment rather than true simple random sampling, and while a potential repeat-visit bias mitigation is described, it was not validated.

Response: Thank you for this insightful comment. We have revised the methods to clarify that the discrepancy reflects practical recruitment constraints rather than methodological issues. We however successfully recruited 393 respondents but 4 were not included in the analysis due to missing data. Also, we have now revised the methods section to clarify the process of selecting participants. Regarding the mitigation of potential repeat-visit bias, we agree that our initial description lacked validation and we have revised our limitations to clearly acknowledged this limitation. We believe these revisions strengthen methodological clarity of the manuscript.

6. Comment: While the authors acknowledge that outcome variables rely entirely on self-report, this could be better contextualised along recall bias, misclassification and social desirability bias risks.

Response: Thank you for this observation. We have revised the limitations to address the possibilities of recall bias, misclassifications and social desirability bias. We have also clarified in our methods and limitations sections and provided a fuller account of both the risks and the mitigation strategies employed. Firstly, that questionnaires were administered as exit interviews, immediately after respondents received treatment which reduced the risk of recall bias. Again, we have noted that we tried to reduce misclassification by providing detailed breakdown of possible health services that may have resulted in payments in the questionnaire and with regards to social desirability bias, we minimised this by conducting the interviews privately.

7. Comment: While the Logistic regression seems appropriate, some missing essentials include variable selection criteria, model diagnostics, multicollinearity checks, and sensitivity analysis. These elements of model transparency would improve rigour. Response: Thank you for this important comment. We could not conduct sensitivity analysis due to the distribution of the outcome variables which limited the potential for meaningful variation across alternative model specifications. We have expanded our limitations to acknowledge this (See Page 27, Lines 494-495).

8. Comment: In result interpretation, the prevalence estimate (97.2%) is extremely high relative to cited Ghanaian literature. While the discussion attributes this to sample homogeneity, this explanation is not empirically demonstrated. Thus, the conclusion risks overstating generalisable burden.

Response: Thank you for this important comment. We have made revisions in our manuscript to ensure that we remain within the limits of our evidence. We have thus accurately presented results, expanded the limitations to fully explain methodological and contextual constraints and revised our conclusions to avoid overstating implications to enhance the credibility of the manuscript.

9. Comment: Several issues require correction as multiple sections contain duplicated or corrupted terms (e.g., OPPsOOP). For instance, percent denominators are sometimes unclear, there are overlapping categories, and Fisher vs Chi-square labelling seem inconsistent.

Response: Thank you for this insightful comment. We have revised the manuscript and corrected all instances of duplication or corrupted text. We have clarified the denominators used for each percentage, ensuring consistency and transparency across tables and narrative results. These corrections improve clarity, accuracy, and consistency throughout the manuscript.

10. Comment: Also, there are some logical phrasing issues such as “findings are important and generalisable”. This is contradicted by the already stated sampling limitations. Again, the claim that findings are generalisable is not sufficiently justified given the single facility, region-specific context, and older patient skew. A revision should reflect analytic relevance, not population generalisability.

Response: Thank you for this important observation. We have made major revisions in our manuscript to ensure that we avoid overstating implications of our findings. We believe this would enhance the credibility of the manuscript.

11. Comment: The revised manuscript does not report any formal robustness or sensitivity analyses beyond the primary logistic regression model. Including some basic model diagnostics or alternative specifications would strengthen confidence in the findings. Given the very high prevalence of OOP payments and reliance on self-reported measures, demonstrating that the main associations are not sensitive to modelling choices would enhance the methodological transparency and credibility of the results.

Response: Thank you for this important observation. Because our study reported a very high prevalence of OOP payments, the scope for meaningful sensitivity analysis was limited given that for such a skewed distribution, sensitivity analyses across subsamples or alternative specifications would not materially change the results, as the imbalance in outcome frequencies constrains model variation. We have acknowledged this in our limitations and noted that future research could consider alternative approaches if outcomes with greater variability are available.

We hope that these revisions satisfactorily address the editor and reviewers’ concerns. We appreciate the opportunity to improve our manuscript and look forward to your feedback.

Thank you for your time and consideration.

Sincerely,

Angela Nana Esi Ackon

angela.aan2009@gmail.com

Attachment

Submitted filename: Response_to_Reviewers_auresp_2.docx

pone.0348971.s005.docx (24.8KB, docx)

Decision Letter 2

Charles Ezenduka

24 Apr 2026

Out-of-pocket payments and associated factors among hypertensive patients insured under the National Health Insurance Scheme in a referral hospital, Ghana

PONE-D-25-08305R2

Dear Dr. Ackon,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Charles C Ezenduka, PhD

Academic Editor

PLOS One

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Charles Ezenduka

PONE-D-25-08305R2

PLOS One

Dear Dr. Ackon,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Charles C Ezenduka

Academic Editor

PLOS One

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Dataset_outofpocketpayments.

    (XLSX)

    pone.0348971.s001.xlsx (53.1KB, xlsx)
    Attachment

    Submitted filename: Dear author.docx

    pone.0348971.s002.docx (14.5KB, docx)
    Attachment

    Submitted filename: Response to Reviewers.docx

    pone.0348971.s004.docx (21KB, docx)
    Attachment

    Submitted filename: Response_to_Reviewers_auresp_2.docx

    pone.0348971.s005.docx (24.8KB, docx)

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES